Major drug manufacturers are set to significantly increase prices for popular medications next year.
An exclusive report by Reuters is based on information obtained as a result of a new law in California that requires pharma companies to notify state agencies of plans to raise the cost of a medication by more than 16 percent over two years.
The companies planning on increasing prices in the new year include Novartis, Bayer, Allergen, Amgen, GlaxoKlineSmith, AstraZeneca and Biogen. In total, 28 companies plan on prices increases substantial enough to trigger the required notification in California.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.